Zynex names Anna Lucsok chief operating officer

Monday February 1, 2021 0 comments Tags: Englewood, Zynex Medical, Anna Lucsok, Thomas Sandgaard

ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) announced it has promoted Anna Lucsok to chief operating officer of Zynex Medical, its pain management division. 

Joseph Papandrea previously held the COO position.Zynex_logoUSE 

"I would personally like to thank Joseph for his leadership and contributions,” said Thomas Sandgaard, Zynex founder and CEO. “We wish him nothing but the best in the future.

“I would also like to congratulate Anna on a well-deserved promotion to COO of Zynex Medical. Anna has been instrumental in transforming our reimbursement and sales operations, which are the backbone of the company, along with our expansions to elevate our patient's experience."

Lucsok previously served as VP of reimbursement and sales operations with Zynex Medical. In that position she was responsible for leading and expanding Zynex's order, reimbursement, patient experience, and inside sales support operations.

During her tenure each of these teams have consistently achieved quarterly targets, while also expanding in size. Lucsok brings more than nine years of healthcare operations experience as well as critical knowledge of revenue cycle management and medical care collections.

She has been involved in various operations positions as well as management positions with Zynex since her start in 2018, including serving as billing manager.

She's previously held key positions with companies such as University of Colorado Hospital, the U.S. Air Force based in Germany and Japan, and Schryver Medical.

Lucsok holds certification in medical billing as well as a degree in Healthcare Administration and Management from Colorado State University.

"I'm honored to take on this new role with the company and I, too, want to thank Joseph for his contributions in setting the stage for our plans as we continue to scale seamlessly in 2021 and beyond,” said Lucsok.

“I'm excited about the opportunities in front of us as our internal and sales teams continue to drive our growth and success, while focusing on providing exceptional patient care."